At TrimRx, we believe that successful weight management starts with having the right information to keep your treatment safe and effective
The stability data that would ordinarily accompany a licensed product including International Council for Harmonisation (ICH) Q1A(R2)-compliant long-term and accelerated stability studies have not been published in a form accessible to prescribers or patients
company announced the result of its SRUMOUNT study conducted on obese patients with a BMI of 30kg/ or more or those with BMI of 27kg/ or more having one or more weight-related comorbidities
Thus, it was widely prescribed
Once injected, semaglutide remains active in the body for an extended period, allowing once-weekly dosing for many patients
A medical treatment plan for obesity should comprise a comprehensive approach including dietary intervention, a physical activity plan, behavioral modification, and pharmacotherapy